Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity*

By U. Pajvani, M. Hawkins, Terry P. Combs, Michael W. Rajala, T. Doebber, J. Berger, J. Wagner, Margaret S. Wu, Annemie Knopps, Anny H. Xiang and 5 more. Journal of Biological Chemistry, 2004

1,194 citations recorded by the source corpus.

Adiponectin is an adipocyte-specific secretory protein that circulates in serum as a hexamer of relatively low molecular weight (LMW) and a larger multimeric structure of high molecular weight (HMW). Serum levels of the protein correlate with systemic insulin sensitivity. The full-length protein affects hepatic gluconeogenesis through improved insulin sensitivity, and a proteolytic fragment of adiponectin stimulates β oxidation in muscle. Here, we show that the ratio, and not the absolute amounts, between these two oligomeric forms (HMW to LMW) is critical in determining insulin sensitivity. We define a new index, SA, that can be calculated as the ratio of HMW/(HMW + LMW). db/db mice, despite similar total adiponectin levels, display decreased SA values compared with wild type littermates, as do type II diabetic patients compared with insulin-sensitive individuals. Furthermore, SA improves with peroxisome proliferator-activated receptor-γ agonist treatment (thiazolidinedione; TZD) in mice and humans. We demonstrate that changes in SA in a number of type 2 diabetic cohorts serve as a quantitative indicator of improvements in insulin sensitivity obtained during TZD treatment, whereas changes in total serum adiponectin levels do not correlate well at the individual level. Acute alterations in SA (ΔSA) are strongly correlated with improvements in hepatic insulin sensitivity and are less relevant as an indicator of improved muscle insulin sensitivity in response to TZD treatment, further underscoring the conclusions from previous clamp studies that suggested that the liver is the primary site of action for the full-length protein. These observations suggest that the HMW adiponectin complex is the active form of this protein, which we directly demonstrate in vivo by its ability to depress serum glucose levels in a dose-dependent manner.

Subfields: Endocrine and Autonomic Systems, Epidemiology, Physiology

View Paper: https://www.semanticscholar.org/paper/fc852d7e72521e7a54bec8dcb7ef4e7111cfcd9b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrine and Autonomic Systems

In Epidemiology

In Physiology

Citations in the corpus

Adipose tissue-derived factors: impact on health and disease. (2006, background): “form (119), highlighting the potential importance of the”
Adiponectin Regulation and Function (2018, positive): “Adiponectin has a relatively long half-life in serum (2.5-6 h), and these levels are determined in part by ultradian patterns (102,241).”
Adipose Tissue (2006, positive): “In fact, we can generalize this statement and argue that type 2 diabetic individuals tend to have lower levels of the HMW form in circulation compared with insulin-sensitive individuals and that the development of type 2 diabetes in an individual is associated with a progressive decrease of the HMW ”
Obesity, inflammation, and atherosclerosis (2009, background): “High-molecular-weight complexes are likely to constitute the most active form of adiponectin and, therefore, levels of high-molecular-weight adiponectin could be a more relevant marker of insulin sensitivity than total circulating adiponectin”
Beneficial effects of subcutaneous fat transplantation on metabolism. (2008, background): “Higher levels of high molec- ular weight (HMW) adiponectin in relation to total adiponectin, but not absolute total adiponectin levels, correlate better with improved insulin sensitivity (Pajvani et al., 2004).”